Speaker Detail

Tyler Jacks is director of the David H. Koch Institute for Integrative Cancer Research and professor of biology at MIT and a Howard Hughes Medical Institute investigator. The biomedical scientist developed mouse models of human cancer that carry mutations in oncogenes and tumor suppressors implicated in many human cancers, demonstrating the decisive roles of such cancer genes through the development of genetically engineered mouse models of lung, pancreas and brain cancers. Jacks served as an advisor to the National Cancer Institute and was president of the American Association of Cancer Research. He oversaw the transformation of the Center for Cancer Research at MIT into the Koch Institute for Integrative Cancer Research, bringing together cancer biologists and bioengineers. He is a member of the National Academy of Sciences and the Institute of Medicine of the National Academies.